Investigated for growth hormone release, IGF-1 signaling, and metabolic research
Third-party verified for identity & purity
Intended for laboratory research use only, NOT FOR HUMAN USE.
Tesamorelin
Reports
Specifications
Tesamorelin
10 mg or 20 mg
Synthetic GHRH Analog
White Lyophilized Peptide
>99%
Research Use Only
Refrigerate 36 - 46F (2 - 8C)
after reconstitution
Product
Strength
Components
Appearance
Purity
Use
Storage
Growth Hormone Research
Tesamorelin is a synthetic growth hormone-releasing (GHRH) analog investigated for its ability to stimulate endogenous growth hormone secretion. Research has focused on endocrine signaling, IFG-1 production, body composition, and metabolic function, making it a valuable compound for laboratory investigation.
Active Components
Synthetic GHRH Analog
Investigated for stimulation of endogenous growth hormone secretion.
Endocrine Signaling
Studied for activation of pituitary growth hormone pathways
IGF-1
Researched focuses on downstream insulin-like growth factor-1 production.
Body Composition
Investigated in studies involving body composition and metabolic physiology.
Research Overview
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog designed to stimulate endogenous growth hormone secretion through activation of pituitary GHRH receptors. Researchers have investigated its effects on endocrine signaling, insulin-like growth-factor-1 (IGF-1) production, body composition, and metabolic function.
Current laboratory research utilizes Tesamorelin to explore growth hormone physiology, endocrine regulation, and metabolic pathways. Its selective mechanism of action has made it a valuable research tool for studies examining growth hormone dynamics and associated biological processes.
For laboratory research use only. Not intended for human or veterinary use.